Clinical Trial Update: Study to Evaluate the Efficacy of Alefacept to Treat Palmar Plantar Pustulosis [Phase 2]

View source ↗

Summary

Phase 2 study evaluating alefacept for palmoplantar pustulosis has completed, reporting on efficacy in psoriasis-related palmar/plantar disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Palmoplantar Pustulosis
• Psoriasis
• Pustular Psoriasis of Palms and Soles

Drugs mentioned

• Amevive (alefacept)

Snippet

Sponsor: The Guenther Dermatology Research Centre | Conditions: Psoriasis, Palmoplantaris Pustulosis | Phase 2 | Status: COMPLETED